- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07617714
Adapted Physical Activity (APA) Following Hospitalization in Frail Older Adults
June 1, 2026 updated by: Biobizkaia Health Research Institute
To evaluate the effectiveness of an Adapted Physical Activity (APA) program in improving functional capacity and reducing frailty in older adults following hospital discharge.
The aim is to determine whether a structured program of personalized exercises improves mobility, strength, and quality of life compared to standard care.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elena Galve, Doctor
- Phone Number: 944006000
- Email: elena.galvecalvo@osakidetza.eus
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The study is open to individuals aged 65 and older.
- Current diagnosis or recent history of cancer.
- Patients currently undergoing treatment (chemotherapy, immunotherapy, targeted therapy) or in follow-up after recent treatment (≤12 months since completion).
- Functional capacity compatible with participation in an adapted physical activity program, as determined by clinical assessment.
- Recent hospitalization: Patients must have been discharged following a hospital stay.
- Frailty: Presence of a significant level of frailty at hospital discharge.
Exclusion Criteria:
- Short Physical Performance Battery> 10: Patients considered "robust" are excluded to maximize the relevance of the intervention.
- Acute unstable medical condition or contraindication to exercise: Any unstabilized acute condition that makes physical activity dangerous (e.g., acute cardiac complication, ongoing severe infection). Recent major medical events (myocardial infarction, major surgery, bone fracture, or major amputation in the past few weeks) will also be excluded.
- Severe chronic conditions incompatible with exercise: Severe progressive diseases that prevent safe exercise, such as severe neuromuscular diseases or advanced organ failure (e.g., end-stage renal failure).
- Short-term life-threatening prognosis: Patients in the terminal phase or with a very limited life expectancy (less than 6 months).
- Total functional dependence or severe motor impairment: Patients who are completely dependent for basic activities (very low Barthel Index, e.g., <20/100) or who are unable to move even minimally (e.g., unable to walk a few steps or stand, even with assistance).
- Severe cognitive impairment: Severe cognitive impairment (e.g., advanced dementia without the ability to follow simple instructions) that prevents active participation in the program.
- Severe sensory or communication disorders: Significant sensory impairments-such as profound uncompensated blindness or deafness-or any communication barrier (severe aphasia, language barrier) that prevents participation in the program, unless a caregiver (family member or professional) can be present to ensure safety during the exercises.
- Institutionalization of the patient: Individuals who do not live in their usual residence are excluded. The study focuses on older adults returning home, as the institutional setting involves different care.
- Lack of valid informed consent: Any patient who refuses to participate or who cannot provide valid consent (due to lack of legal capacity or understanding) will be excluded.
- Participation in another concurrent program or trial: Simultaneous participation in another physical exercise program or trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Adapted Physical Activity Program
|
a 14-week Adapted Physical Activity (APA) program following hospital discharge
|
|
Other: routine care
|
Participants in the control group will receive standard post-discharge care, along with general recommendations for physical activity and healthy lifestyle habits
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Improvement in overall physical function assessed by changes in the Short Physical Performance Battery (SPPB) score."
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
May 22, 2026
First Submitted That Met QC Criteria
May 29, 2026
First Posted (Actual)
June 1, 2026
Study Record Updates
Last Update Posted (Actual)
June 2, 2026
Last Update Submitted That Met QC Criteria
June 1, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- SHAPE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oncologic Disease
-
Tomas Bata Hospital, Czech RepublicActive, not recruitingOncologic Disease | SeniorCzechia
-
Atlas UniversityRecruitingChemotherapy | Oncologic DiseaseTurkey (Türkiye)
-
Meyer Children's Hospital IRCCSRecruitingHematologic Diseases | Oncologic DiseaseItaly
-
Nantes University HospitalNot yet recruitingReconstruction of Massive Bone Loss (Oncologic and Non-oncologic)France
-
Centro di Riferimento Oncologico - AvianoRecruiting
-
Azienda Unita Sanitaria Locale Reggio EmiliaCompletedOncologic ComplicationsItaly
-
ARCIM Institute Academic Research in Complementary...Completed
-
Ilyse KenisKU Leuven; University Ghent; Kom Op Tegen KankerUnknownOncologic DisordersBelgium
-
University of Sao PauloNetherlands: Ministry of Health, Welfare and SportsCompletedOncologic Patients
Clinical Trials on Adapted Physical Activity Program
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
University Hospital, ToulouseRecruiting
-
University Hospital, ToulouseRecruiting
-
University Hospital, Montpelliermooven societyTerminated
-
Institut Cancerologie de l'OuestUniversity of PoitiersUnknown
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
University Hospital, ToulouseCompleted
-
CHU de ReimsUnknownAdapted Physical Activity and CancerFrance
-
Assistance Publique - Hôpitaux de ParisEuromov Digital Health in Motion Montpellier FranceCompleted